Tradestie Institutional Equity Comparison Engine
VVOS vs BVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BVS Overall Edge
BVS Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bioventus Inc. Class A Common Stock (BVS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus BVS at 11.1x Forward P/E and 10.1% operating margin (+2.7% YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against BVS sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
BVS
VVOS N/M vs BVS 11.1x Fwd P/E
Growth & Margin Winner
BVS
Op Margin -107.9% vs 10.1% ยท YoY +34.9% vs +2.7%
Momentum & Technical Winner
BVS
1Y -97.7% vs +47.0% ยท 52W Pos 0% vs 36%
Options & Structure Winner
BVS
BREAKDOWN (N/A IV) vs BREAKDOWN (100th %ile IV)
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
BVS
NASDAQ
Bioventus Inc. Class A Common Stock
Surgical & Medical Instruments & Apparatus
$9.88
-0.7% 1D
Market Cap
$681.3M
1M Return
-34.31%
1Y Return
+47.02%
Forward P/E
11.1x
Unified AI Score
46.2 / 100
HOLD
Tech 35.0
Fund 49.0
Flow 64.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VVOS -97.71%
BVS +47.02%
Spread: +144.73 pp (BVS Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | VVOS Revenue | BVS Revenue | VVOS Op. Margin | BVS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | $340M | -92.8% | 9.2% | BVS |
| FY2020 | $10M | $320M | -92.1% | 6.6% | BVS |
| FY2021 | $20M | $430M | -120.7% | 2.8% | BVS |
| FY2022 | $20M | $510M | -156.2% | -32.7% | BVS |
| FY2023 | $10M | $510M | -125.3% | -16.0% | BVS |
| FY2024 | $20M | $570M | -74.3% | -2.7% | BVS |
| FY2025 | $20M | $570M | -114.1% | 9.5% | BVS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VVOS | BVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9M | $681.3M | Larger Scale | BVS |
| Trailing P/E Ratio Valuation | N/M | 12.3x | Lower Multiple | BVS |
| Forward P/E Ratio Valuation | N/M | 11.1x | Lower Multiple | BVS |
| Revenue Growth (YoY) Growth | +34.9% | +2.7% | Higher Growth | VVOS |
| Operating Margin (TTM) Profitability | -107.9% | 10.1% | Higher Margin | BVS |
| Net Profit Margin Profitability | -121.8% | 9.8% | Higher Margin | BVS |
| Return on Equity (ROE) Capital Efficiency | -8585.3% | 25.8% | Higher ROE | BVS |
| 52-Week Range Position Momentum | 0% ($0โ$3) | 36% ($6โ$16) | Stronger Trend | BVS |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 111% Vol | 0.85ฮฒ ยท 74% Vol | Lower Realized Risk | BVS |
| Unified Institutional Score Composite Signal | 36.4 / 100 (SELL) | 46.2 / 100 (HOLD) | Higher Composite | BVS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VVOS vs BVS Buy Guide
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BVS
BREAKDOWN
76d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VVOS nor BVS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.